
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 887.00 |
| High | 887.00 |
| Low | 863.00 |
| Prev Close | 875.85 |
| Volume | 57,490 |
| VWAP(₹) | 869.84 |
| PE Ratio(x) | 47.42 |
| EPS - TTM(₹) | 18.30 |
| MCap(₹ Cr.) | 10,429.15 |
| MCap Rank | 5 |
| PB Ratio(x) | 5.23 |
| Div Yield(%) | - |
| Face Value(₹) | 2.00 |
| 52W High(₹) | 1,022.20 |
| 52W Low(₹) | 732.00 |
| MCap/Sales | 1.46 |
| Beta(1 Month) | - |
| BV/Share(₹) | 164.48 |
Employee & Interest Expense
Company has spent 1.75% of its operating revenues towards interest expenses and 12.83% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)Medplus Health Serv Share Price Update
Medplus Health Services Ltd. share price moved down by -0.57% from its previous close of Rs 875.85. Medplus Health Services Ltd. stock last traded price is 870.90
| Share Price | Value |
|---|---|
| Today/Current/Last | 870.90 |
| Previous Day | 875.85 |
Found Insights useful?
| 1 Day | -0.57% |
| 1 Month | 0.23% |
| 3 Months | 3.18% |
| 1 Year | -2.06% |
| 3 Years | 11.5% |
| 5 Years | N.A. |
7 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 |
| Hold | - | - | - | - |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 7 | 7 | 6 | 6 |
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analysts
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analysts
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analysts
Announcement under Regulation 30 (LODR)-Cessation
Announcements| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|
| Total Income | 1,884.98 | 1,824.36 | 1,696.80 | 1,557.65 | 1,525.40 |
| Total Income Growth (%) | 3.32 | 7.52 | 8.93 | 2.11 | -3.09 |
| Total Expenses | 1,771.16 | 1,720.28 | 1,599.04 | 1,477.52 | 1,437.44 |
| Total Expenses Growth (%) | 2.96 | 7.58 | 8.22 | 2.79 | -3.62 |
| EBIT | 113.82 | 104.08 | 97.75 | 80.13 | 87.96 |
| EBIT Growth (%) | 9.36 | 6.47 | 21.99 | -8.90 | 6.52 |
| Profit after Tax (PAT) | 63.98 | 57.81 | 55.50 | 42.36 | 51.34 |
| PAT Growth (%) | 10.68 | 4.15 | 31.03 | -17.49 | 11.88 |
| EBIT Margin (%) | 6.04 | 5.70 | 5.76 | 5.14 | 5.77 |
| Net Profit Margin (%) | 3.39 | 3.17 | 3.27 | 2.72 | 3.37 |
| Basic EPS (₹) | 5.33 | 4.82 | 4.63 | 3.54 | 4.32 |
All figures in Rs Cr, unless mentioned otherwise
Employee & Interest Expense
Company has spent 1.75% of its operating revenues towards interest expenses and 12.83% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Assets | 3,932.53 | 3,360.10 | 3,004.80 | 2,796.72 | 2,594.05 |
| Total Assets Growth (%) | 17.04 | 11.82 | 7.44 | 7.81 | 65.68 |
| Total Liabilities | 1,957.87 | 1,620.20 | 1,427.44 | 1,306.22 | 1,176.80 |
| Total Liabilities Growth (%) | 20.84 | 13.50 | 9.28 | 11.00 | 41.01 |
| Total Equity | 1,974.65 | 1,739.90 | 1,577.36 | 1,490.50 | 1,417.25 |
| Total Equity Growth (%) | 13.49 | 10.30 | 5.83 | 5.17 | 293.36 |
| Current Ratio (x) | 3.00 | 3.20 | 2.98 | 3.11 | 2.92 |
| Total Debt to Equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Contingent Liabilities | 0.00 | 14.65 | 16.66 | 18.24 | 32.84 |
All figures in Rs Cr, unless mentioned otherwise
| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Net Cash flow from Operating Activities | 495.58 | 540.43 | 143.74 | 90.41 | 169.89 |
| Net Cash used in Investing Activities | -127.72 | -317.61 | -82.80 | 429.44 | -703.13 |
| Net Cash flow from Financing Activities | -255.51 | -227.98 | -198.10 | -170.25 | 440.43 |
| Net Cash Flow | 112.36 | -5.16 | -137.17 | 349.60 | -92.81 |
| Closing Cash & Cash Equivalent | 198.41 | 86.05 | 91.21 | 228.38 | -121.23 |
| Closing Cash & Cash Equivalent Growth (%) | 130.57 | -5.65 | -60.06 | -288.39 | 326.57 |
| Total Debt/ CFO (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.84 |
All figures in Rs Cr, unless mentioned otherwise
Decrease in Cash from Investing
Company has used Rs 127.72 cr for investing activities which is an YoY decrease of 59.79%. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Return on Equity (%) | 11.11 | 8.63 | 4.14 | 3.33 | 6.75 |
| Return on Capital Employed (%) | 12.20 | 10.27 | 6.85 | 5.61 | 9.05 |
| Return on Assets (%) | 5.58 | 4.47 | 2.17 | 1.77 | 3.69 |
| Interest Coverage Ratio (x) | 5.63 | 5.22 | 4.09 | 3.75 | 4.57 |
| Asset Turnover Ratio (x) | 1.89 | 1.93 | 1.94 | 1.69 | 0.11 |
| Price to Earnings (x) | 45.87 | 60.61 | 126.58 | 156.25 | 126.58 |
| Price to Book (x) | 5.09 | 5.22 | 5.22 | 5.21 | 8.50 |
| EV/EBITDA (x) | 14.14 | 16.28 | 20.55 | 24.01 | 40.04 |
| EBITDA Margin (%) | 9.84 | 8.73 | 7.00 | 6.84 | 8.03 |
Found Financials useful?
No Data Available
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
| R1 | - | Pivot - | S1 | - |
| R2 | - | S2 | - | |
| R3 | - | S3 | - |
| 5 Days | 14 Days | 28 Days |
| - | - | - |
Choose from Peers
Choose from Stocks
Found Peer Comparison useful?
MF Ownership as on 30 April 2026
380.73
Amount Invested (in Cr.)
1.22%
% of AUM
0.00
% Change (MoM basis)
316.35
Amount Invested (in Cr.)
3.78%
% of AUM
0.00
% Change (MoM basis)
312.09
Amount Invested (in Cr.)
1.79%
% of AUM
0.00
% Change (MoM basis)
Board Meeting
Audited Results
May 04, 2026
Board Meeting
Audited Results
May 04, 2026
General Meeting
-
Feb 25, 2026
| Announced on | Meeting on |
| May 04, 2026 | May 29, 2026 |
| Audited Results | |
| May 04, 2026 | May 20, 2026 |
| Audited Results | |
| Jan 05, 2026 | Jan 30, 2026 |
| Quarterly Results | |
| Oct 01, 2025 | Oct 31, 2025 |
| Quarterly Results | |
| Jul 10, 2025 | Aug 02, 2025 |
| Quarterly Results | |
No Data Available
No Data Available
No Data Available
No Data Available
| Announced on | Meeting on |
| Feb 25, 2026 | Mar 28, 2026 |
| - | |
| Aug 22, 2025 | Sep 15, 2025 |
| - | |
| Feb 11, 2025 | Mar 14, 2025 |
| - | |
| Aug 02, 2024 | Sep 26, 2024 |
| - | |
| Nov 13, 2023 | Dec 15, 2023 |
| - | |
Medplus Health Services Ltd., incorporated in the year 2006, is a Small Cap company (having a market cap of Rs 10,514.99 Crore) operating in Retail sector.
Industry
Key Indices Listed On
BSE 500, BSE 250 SmallCap Index, BSE SmallCap, BSE Consumer Discretionary, BSE 400 MidSmallCap Index
Address
H. No: 11-6-56, Survey No: 257 & 258/1,Opp: IDPL Railway Siding Road,Hyderabad, Telangana - 500037
Gangadi Madhukar Reddy
Chairman & M.D & CEOCherukupalli Bhaskar Reddy
Whole Time Director & COOAparna Surabhi
Ind. Non-Executive DirectorMadhavan Ganesan
Ind. Non-Executive DirectorDATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.